PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,405,000 | -46.5% | 350,000 | -30.0% | 1.01% | -14.4% |
Q1 2022 | $38,160,000 | -62.8% | 500,000 | -70.7% | 1.18% | -62.9% |
Q4 2021 | $102,626,000 | +45.5% | 1,705,599 | +35.4% | 3.16% | +57.5% |
Q3 2021 | $70,533,000 | -8.7% | 1,259,518 | -1.1% | 2.01% | +8.8% |
Q2 2021 | $77,255,000 | -22.0% | 1,273,161 | -10.0% | 1.85% | -18.9% |
Q1 2021 | $99,097,000 | +17.1% | 1,413,854 | 0.0% | 2.28% | +3.6% |
Q4 2020 | $84,605,000 | +12.1% | 1,413,854 | +12.6% | 2.20% | -6.7% |
Q3 2020 | $75,487,000 | +11.5% | 1,255,608 | -2.7% | 2.35% | +8.8% |
Q2 2020 | $67,683,000 | +17.6% | 1,289,941 | -24.9% | 2.16% | -1.5% |
Q1 2020 | $57,562,000 | -26.0% | 1,716,727 | 0.0% | 2.20% | +30.8% |
Q4 2019 | $77,768,000 | +19.0% | 1,716,727 | 0.0% | 1.68% | +28.3% |
Q3 2019 | $65,356,000 | +56.7% | 1,716,727 | +79.0% | 1.31% | +84.6% |
Q2 2019 | $41,707,000 | +119.2% | 958,997 | +91.8% | 0.71% | +249.3% |
Q1 2019 | $19,030,000 | – | 500,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |